- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 1 x JQR: ~{N}-[4-(furan-2-yl)-5-(oxan-4-ylcarbonyl)-1,3-thiazol-2-yl]-6-methyl-pyridine-3-carboxamide(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
CLR.2: 7 residues within 4Å:- Chain A: F.191, L.352, C.359, F.360, F.363, C.364
- Ligands: OLC.5
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.191, A:L.352, A:F.360, A:F.360, A:F.360, A:F.360, A:F.363
CLR.3: 9 residues within 4Å:- Chain A: L.67, F.71, A.81, A.82, G.85, F.88, I.89
- Ligands: OLC.13, OLC.21
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.67, A:F.71, A:A.81, A:F.88, A:I.89, A:I.89
- Hydrogen bonds: A:A.82
- Water bridges: A:Q.172
CLR.4: 8 residues within 4Å:- Chain A: L.349, P.353, I.356, I.357, F.360, C.367, S.368, L.374
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.349, A:P.353, A:I.356, A:I.356, A:I.357, A:F.360, A:F.360, A:L.374
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLC.5: 5 residues within 4Å:- Chain A: F.192, L.196, F.363
- Ligands: CLR.2, OLC.12
Ligand excluded by PLIPOLC.6: 11 residues within 4Å:- Chain A: G.14, V.17, Y.18, V.21, C.350, W.373, Y.376, V.380, T.384, V.388
- Ligands: OLC.17
Ligand excluded by PLIPOLC.7: 8 residues within 4Å:- Chain A: Y.52, V.55, A.59, F.92, G.127, K.131, W.138
- Ligands: OLC.8
Ligand excluded by PLIPOLC.8: 11 residues within 4Å:- Chain A: C.37, V.40, W.41, Q.47, Y.52, V.55, A.59, I.62, L.67
- Ligands: OLC.7, OLC.16
Ligand excluded by PLIPOLC.9: 2 residues within 4Å:- Ligands: OLC.20, OLC.21
Ligand excluded by PLIPOLC.10: 3 residues within 4Å:- Chain A: V.27, T.77
- Ligands: OLC.20
Ligand excluded by PLIPOLC.11: 5 residues within 4Å:- Chain A: Y.188, F.192, A.193, F.362
- Ligands: OLC.12
Ligand excluded by PLIPOLC.12: 6 residues within 4Å:- Chain A: Y.188, F.192, V.197, F.363
- Ligands: OLC.5, OLC.11
Ligand excluded by PLIPOLC.13: 5 residues within 4Å:- Chain A: A.82, H.84, G.85
- Ligands: CLR.3, OLC.14
Ligand excluded by PLIPOLC.14: 3 residues within 4Å:- Chain A: H.84, L.146
- Ligands: OLC.13
Ligand excluded by PLIPOLC.15: 1 residues within 4Å:- Chain A: L.211
Ligand excluded by PLIPOLC.16: 5 residues within 4Å:- Chain A: C.37, W.41
- Ligands: OLC.8, OLC.21, OLC.22
Ligand excluded by PLIPOLC.17: 9 residues within 4Å:- Chain A: I.25, L.28, V.387, V.388, F.391, I.392, Y.395, R.396
- Ligands: OLC.6
Ligand excluded by PLIPOLC.18: 7 residues within 4Å:- Chain A: I.109, Y.112, I.113, L.124, A.193, C.194, P.198
Ligand excluded by PLIPOLC.19: 7 residues within 4Å:- Chain A: A.106, I.109, D.110, L.124, V.125, R.129, I.133
Ligand excluded by PLIPOLC.20: 6 residues within 4Å:- Chain A: P.70, T.74, F.79
- Ligands: OLC.9, OLC.10, OLC.21
Ligand excluded by PLIPOLC.21: 8 residues within 4Å:- Chain A: F.71, T.74, F.79, C.80
- Ligands: CLR.3, OLC.9, OLC.16, OLC.20
Ligand excluded by PLIPOLC.22: 6 residues within 4Å:- Chain A: V.34, W.38, W.41, L.42, H.411
- Ligands: OLC.16
Ligand excluded by PLIP- 1 x PE4: 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohno, Y. et al., In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A 2A Receptor Antagonist/Inverse Agonist. Mol.Pharmacol. (2023)
- Release Date
- 2023-03-22
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 1 x JQR: ~{N}-[4-(furan-2-yl)-5-(oxan-4-ylcarbonyl)-1,3-thiazol-2-yl]-6-methyl-pyridine-3-carboxamide(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- 1 x PE4: 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohno, Y. et al., In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A 2A Receptor Antagonist/Inverse Agonist. Mol.Pharmacol. (2023)
- Release Date
- 2023-03-22
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.